Afatinib enhances the efficacy of conventional chemotherapeutic agents by eradicating cancer stem-like cells.
about
Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells.Afatinib circumvents multidrug resistance via dually inhibiting ATP binding cassette subfamily G member 2 in vitro and in vivo.Targeting nodal in conjunction with dacarbazine induces synergistic anticancer effects in metastatic melanomaPhotochemical internalisation, a minimally invasive strategy for light-controlled endosomal escape of cancer stem cell-targeting therapeutics.MicroRNA-153/Nrf-2/GPx1 pathway regulates radiosensitivity and stemness of glioma stem cells via reactive oxygen speciesKCTD12 Regulates Colorectal Cancer Cell Stemness through the ERK Pathway.Molecular Pathways: Targeting Cancer Stem Cells Awakened by Chemotherapy to Abrogate Tumor Repopulation.Lithium chloride has a biphasic effect on prostate cancer stem cells and a proportional effect on midkine levels.Induced cancer stem cells generated by radiochemotherapy and their therapeutic implications.CUDC-907, a dual HDAC and PI3K inhibitor, reverses platinum drug resistance.Investigational ErbB-2 tyrosine kinase inhibitors for the treatment of breast cancer.ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview.Chemotherapy and intercalated gefitinib or erlotinib in the treatment of advanced non-small-cell lung cancer.ABCG2 overexpression in patients with acute myeloid leukemia: Impact on stem cell transplantation outcome.YM155 as an inhibitor of cancer stemness simultaneously inhibits autophosphorylation of epidermal growth factor receptor and G9a-mediated stemness in lung cancer cells.Overexpression of lncRNA NEAT1 mitigates multidrug resistance by inhibiting ABCG2 in leukemiaStructure Identification and In Vitro Anticancer Activity of Lathyrol-3-phenylacetate-5,15-diacetate.Stemness and anti-cancer drug resistance in ATP-binding cassette subfamily G member 2 highly expressed pancreatic cancer is induced in 3D culture conditions.
P2860
Q33591405-9B25668F-C361-491C-868F-4636F8B71776Q35067898-C2BDE9EA-4A0D-4511-A98F-6D0061A342C8Q35434352-E2D5887A-9B98-4460-A9C8-7447FCD6B3F8Q35585820-B4FBA3BD-EE5D-448B-BFFD-CEDA3D4DBFE8Q36355853-A9E63D38-2F1D-48C3-95AC-DDABA6F1456AQ36548661-02D68DC2-F0B2-4C64-AE75-A07600E8E58DQ37025965-D6414DAF-9B97-4752-9445-34D51D4B2F4AQ37289486-4E6C765B-B04F-4BEF-95EC-D93A8E5DD6A3Q37725612-6BBD5167-179F-468C-88AF-B2E8DC17897EQ38618905-2C7A5B29-8906-40FA-82F1-C527F4713595Q38728508-92B55799-EDBF-45F8-AFBD-6D1476C35859Q38908841-2A1AE0F5-FB32-430D-9FB7-8B31B1AD1C64Q38983980-1F551E76-E09C-44C3-BD8D-59B417174FEEQ40852245-557A34E3-7E5A-47F3-8BE1-BB9FB162CFFAQ41281151-53EEA7C7-CBB0-41A5-B94E-4D7CCA8CFF5FQ41827476-C64DED39-6410-4555-A67B-42546820D56BQ46316359-B5611041-EB7C-4209-9B0F-02949858D174Q49997308-3A82E586-1980-4BFE-9711-57EED11CB006
P2860
Afatinib enhances the efficacy of conventional chemotherapeutic agents by eradicating cancer stem-like cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Afatinib enhances the efficacy ...... cating cancer stem-like cells.
@en
type
label
Afatinib enhances the efficacy ...... cating cancer stem-like cells.
@en
prefLabel
Afatinib enhances the efficacy ...... cating cancer stem-like cells.
@en
P2093
P1433
P1476
Afatinib enhances the efficacy ...... cating cancer stem-like cells.
@en
P2093
Jie-hua He
Jing-hong Xu
Xiao-kun Wang
Zhen-cong Huang
P304
P356
10.1158/0008-5472.CAN-13-3553
P407
P577
2014-06-27T00:00:00Z